Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Marpai, Inc. (MRAI : NSDQ)
 
 • Company Description   
Marpai Inc. is an AI-driven health tech company transforming third party administration in the self-funded market. Marpai Inc. is based in TAMPA, Fla.

Number of Employees: 148

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.95 Daily Weekly Monthly
20 Day Moving Average: 25,608 shares
Shares Outstanding: 21.25 (millions)
Market Capitalization: $20.19 (millions)
Beta: 0.78
52 Week High: $2.42
52 Week Low: $0.69
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -0.01% 1.60%
12 Week 21.80% 18.73%
Year To Date 31.94% 28.30%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
5701 EAST HILLSBOROUGH AVENUE SUITE 1417
-
TAMPA,FL 33610
USA
ph: 646-303-3483
fax: -
ir@marpaihealth.com http://www.marpaihealth.com
 
 • General Corporate Information   
Officers
Edmundo Gonzalez - Chief Executive Officer; Secretary and Director
Yaron Eitan - Chairman of the Board of Directors
Yoram Bibring - Principal Financial Officer and Accounting Officer
Damien Lamendola - Director
Gonen Antebi - Director

Peer Information
Marpai, Inc. (EVOL)
Marpai, Inc. (RAMP)
Marpai, Inc. (ALOT)
Marpai, Inc. (TGHI)
Marpai, Inc. (GNCMA)
Marpai, Inc. (GSIC)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Technology Services
Sector: Business Services
CUSIP: 571354109
SIC: 8090
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/22
Next Expected EPS Date: 03/29/23
Share - Related Items
Shares Outstanding: 21.25
Most Recent Split Date: (:1)
Beta: 0.78
Market Capitalization: $20.19 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 03/29/23  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.40
Price/Cash Flow: -
Price / Sales: 0.89
EPS Growth
vs. Year Ago Period: 40.43%
vs. Previous Quarter: 17.65%
Sales Growth
vs. Year Ago Period: 2.90%
vs. Previous Quarter: -11.14%
ROE
12/31/22 - -
09/30/22 - -108.51
06/30/22 - -116.50
ROA
12/31/22 - -
09/30/22 - -67.21
06/30/22 - -63.56
Current Ratio
12/31/22 - -
09/30/22 - 1.20
06/30/22 - 1.65
Quick Ratio
12/31/22 - -
09/30/22 - 1.20
06/30/22 - 1.65
Operating Margin
12/31/22 - -
09/30/22 - -104.66
06/30/22 - -100.92
Net Margin
12/31/22 - -
09/30/22 - -104.66
06/30/22 - -100.92
Pre-Tax Margin
12/31/22 - -
09/30/22 - -104.66
06/30/22 - -100.91
Book Value
12/31/22 - -
09/30/22 - 0.68
06/30/22 - 0.94
Inventory Turnover
12/31/22 - -
09/30/22 - -
06/30/22 - -
Debt-to-Equity
12/31/22 - -
09/30/22 - 0.00
06/30/22 - 0.00
Debt-to-Capital
12/31/22 - -
09/30/22 - 0.00
06/30/22 - 0.00
 

Powered by Zacks Investment Research ©